EU Extends Ozempic Review to Include More Weight-loss, Diabetes Drugs
The European Medicines Agency (EMA) said on Tuesday it has extended its probe into Novo Nordisk’s diabetes drugs Ozempic and weight-loss treatment Saxenda, following two reports of suicidal thoughts, to include otherRead More…